238 related articles for article (PubMed ID: 9341182)
1. Overexpression, purification, characterization, and crystallization of the BTB/POZ domain from the PLZF oncoprotein.
Li X; Lopez-Guisa JM; Ninan N; Weiner EJ; Rauscher FJ; Marmorstein R
J Biol Chem; 1997 Oct; 272(43):27324-9. PubMed ID: 9341182
[TBL] [Abstract][Full Text] [Related]
2. In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions.
Melnick A; Ahmad KF; Arai S; Polinger A; Ball H; Borden KL; Carlile GW; Prive GG; Licht JD
Mol Cell Biol; 2000 Sep; 20(17):6550-67. PubMed ID: 10938130
[TBL] [Abstract][Full Text] [Related]
3. Structure-function studies of the BTB/POZ transcriptional repression domain from the promyelocytic leukemia zinc finger oncoprotein.
Li X; Peng H; Schultz DC; Lopez-Guisa JM; Rauscher FJ; Marmorstein R
Cancer Res; 1999 Oct; 59(20):5275-82. PubMed ID: 10537309
[TBL] [Abstract][Full Text] [Related]
4. Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors.
Melnick A; Carlile G; Ahmad KF; Kiang CL; Corcoran C; Bardwell V; Prive GG; Licht JD
Mol Cell Biol; 2002 Mar; 22(6):1804-18. PubMed ID: 11865059
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of the BTB domain from PLZF.
Ahmad KF; Engel CK; Privé GG
Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12123-8. PubMed ID: 9770450
[TBL] [Abstract][Full Text] [Related]
6. The integrity of the charged pocket in the BTB/POZ domain is essential for the phenotype induced by the leukemia-associated t(11;17) fusion protein PLZF/RARalpha.
Puccetti E; Zheng X; Brambilla D; Seshire A; Beissert T; Boehrer S; Nürnberger H; Hoelzer D; Ottmann OG; Nervi C; Ruthardt M
Cancer Res; 2005 Jul; 65(14):6080-8. PubMed ID: 16024608
[TBL] [Abstract][Full Text] [Related]
7. Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene.
Davies JM; Hawe N; Kabarowski J; Huang QH; Zhu J; Brand NJ; Leprince D; Dhordain P; Cook M; Morriss-Kay G; Zelent A
Oncogene; 1999 Jan; 18(2):365-75. PubMed ID: 9927193
[TBL] [Abstract][Full Text] [Related]
8. Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyelocytic leukemia zinc finger-retinoic acid receptor-alpha fusion protein.
Dong S; Zhu J; Reid A; Strutt P; Guidez F; Zhong HJ; Wang ZY; Licht J; Waxman S; Chomienne C; Chen Z; Zelent A; Chen SJ
Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3624-9. PubMed ID: 8622986
[TBL] [Abstract][Full Text] [Related]
9. The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT.
Huynh KD; Bardwell VJ
Oncogene; 1998 Nov; 17(19):2473-84. PubMed ID: 9824158
[TBL] [Abstract][Full Text] [Related]
10. The acute promyelocytic leukemia-associated protein, promyelocytic leukemia zinc finger, regulates 1,25-dihydroxyvitamin D(3)-induced monocytic differentiation of U937 cells through a physical interaction with vitamin D(3) receptor.
Ward JO; McConnell MJ; Carlile GW; Pandolfi PP; Licht JD; Freedman LP
Blood; 2001 Dec; 98(12):3290-300. PubMed ID: 11719366
[TBL] [Abstract][Full Text] [Related]
11. The ETO protein disrupted in t(8;21)-associated acute myeloid leukemia is a corepressor for the promyelocytic leukemia zinc finger protein.
Melnick AM; Westendorf JJ; Polinger A; Carlile GW; Arai S; Ball HJ; Lutterbach B; Hiebert SW; Licht JD
Mol Cell Biol; 2000 Mar; 20(6):2075-86. PubMed ID: 10688654
[TBL] [Abstract][Full Text] [Related]
12. Colocalization and heteromerization between the two human oncogene POZ/zinc finger proteins, LAZ3 (BCL6) and PLZF.
Dhordain P; Albagli O; Honore N; Guidez F; Lantoine D; Schmid M; The HD; Zelent A; Koken MH
Oncogene; 2000 Dec; 19(54):6240-50. PubMed ID: 11175338
[TBL] [Abstract][Full Text] [Related]
13. Sequence-specific DNA binding and transcriptional regulation by the promyelocytic leukemia zinc finger protein.
Li JY; English MA; Ball HJ; Yeyati PL; Waxman S; Licht JD
J Biol Chem; 1997 Sep; 272(36):22447-55. PubMed ID: 9278395
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of the BTB domain from the LRF/ZBTB7 transcriptional regulator.
Stogios PJ; Chen L; Privé GG
Protein Sci; 2007 Feb; 16(2):336-42. PubMed ID: 17189472
[TBL] [Abstract][Full Text] [Related]
15. Recruitment of SMRT/N-CoR-mSin3A-HDAC-repressing complexes is not a general mechanism for BTB/POZ transcriptional repressors: the case of HIC-1 and gammaFBP-B.
Deltour S; Guerardel C; Leprince D
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14831-6. PubMed ID: 10611298
[TBL] [Abstract][Full Text] [Related]
16. A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF.
Hoatlin ME; Zhi Y; Ball H; Silvey K; Melnick A; Stone S; Arai S; Hawe N; Owen G; Zelent A; Licht JD
Blood; 1999 Dec; 94(11):3737-47. PubMed ID: 10572087
[TBL] [Abstract][Full Text] [Related]
17. A beta-sheet interaction interface directs the tetramerisation of the Miz-1 POZ domain.
Stead MA; Trinh CH; Garnett JA; Carr SB; Baron AJ; Edwards TA; Wright SC
J Mol Biol; 2007 Nov; 373(4):820-6. PubMed ID: 17880999
[TBL] [Abstract][Full Text] [Related]
18. The BTB domain of bric à brac mediates dimerization in vitro.
Chen W; Zollman S; Couderc JL; Laski FA
Mol Cell Biol; 1995 Jun; 15(6):3424-9. PubMed ID: 7760839
[TBL] [Abstract][Full Text] [Related]
19. The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain.
Deweindt C; Albagli O; Bernardin F; Dhordain P; Quief S; Lantoine D; Kerckaert JP; Leprince D
Cell Growth Differ; 1995 Dec; 6(12):1495-503. PubMed ID: 9019154
[TBL] [Abstract][Full Text] [Related]
20. Fusion protein of retinoic acid receptor alpha with promyelocytic leukemia protein or promyelocytic leukemia zinc finger protein recruits N-CoR-TBLR1 corepressor complex to repress transcription in vivo.
Tomita A; Buchholz DR; Obata K; Shi YB
J Biol Chem; 2003 Aug; 278(33):30788-95. PubMed ID: 12794076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]